The meeting will be held in College Park, Maryland, and will seek to raise awareness about the potential for EMA and solicit input and comments on how industry regulators and other parties can better predict, prevent and address EMA. Of specific interest will be how EMA can be addressed in food, dietary supplements, animal food, drugs, cosmetic products and all associated ingredients.
The FDA is seeking input on the following questions:
· What information should U.S. regulators seek and from what sources to help predict and prevent EMA? What further steps can U.S. regulators take to predict and prevent EMA?
· What are members of industry doing to prevent EMA? What further steps can industry take to prevent EMA?
· What recent examples of known or suspected EMA domestically and internationally should U.S. regulators study and learn from?
· What information do other organizations (including, but not limited to, trade organizations and security service providers) have that would be useful in predicting and preventing EMA? What are members of other organizations doing to prevent EMA?
· What are other government regulators within and outside of the United States doing to predict and address EMA?
· What indicators (economic-based, chemistry-based, etc.) might be used to detect potential EMA?
The FDA is also seeking input on what products or ingredients may be at risk for EMA, as well as potential detection methods. More information is available here.
Related NBJ links:
FDA Sets Melamine Standard for Formula after Traces of Chemical Found in U.S.-Made Products
Industry Warns FDA that Broad Interpretation of Section 912 Could Trample Supplement, Food Ingredient Innovation
Natural Products Foundation Urges full Enforcement of the Law Regarding False Advertising for Dietary Supplements